Look almost anywhere in your home and you’ll likely find something made of silicone. Unfortunately, manufacturing silicone-based materials comes with a high environmental cost that is largely due to ...
Maze Therapeutics, a kidney disease therapy developer, recently IPO-ed with a market cap of $487mn and significant early-stage investor backing. Lead asset MZE829 targets APOL1 Kidney Disease, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback